No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1124 |
4. Check minimum number of eventsNone |
1124 |
5. Include endpointsNone |
1124 |
6. Filter based on genotype QC (FinnGen only) |
1124 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I60-I69
- Name in latin
- Alia haemorrhagia intracranialis non traumatica
Similar endpoints
↥List of similar endpoints to
Other intracranial haemorrhages
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases
- Bleeding
- STROKE
- Neurological diseases, wide definition
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10757 | 4015 | 6617 |
| Only index persons | 8357 | 3132 | 5225 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.16 | 0.12 | 0.18 |
| Only index persons | 0.17 | 0.12 | 0.20 |
| Median age at first event (years) | |||
| Whole population | 74.17 | 76.06 | 73.01 |
| Only index persons | 73.90 | 75.44 | 72.98 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1124 | 356 | 768 |
| Unadjusted period prevalence (%) | 0.27 | 0.12 | 0.34 |
| Median age at first event (years) | 72.47 | 69.31 | 73.94 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1013
- Matched controls
- 10130
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
64.4
323.0
512
158
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
121.7
323.0
422
59
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
16384.0
323.0
770
*
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
+∞
237.0
218
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
139.8
193.4
202
18
AA1AD
NOMESCO Finland
CT of head and brain
8.0
190.0
572
1414
I62.1
ICD-10 Finland
Nontraumatic extradural haemorrhage
+∞
115.9
109
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
58.9
110.0
129
25
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
76.0
72
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.6
75.4
490
2096
X59
ICD-10 Finland
Exposure to unspecified factor
4.4
74.4
321
958
W19
ICD-10 Finland
Unspecified fall
5.6
66.9
218
475
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
332.5
62.1
62
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
19.2
60.2
93
53
K90
ICPC
Stroke/cerebrovascular accident
29.2
59.7
81
30
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
85.3
57.7
64
8
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
589.6
57.2
56
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
56.8
54
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
273.9
51.6
52
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
7.4
42.2
105
156
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
41.5
283
1140
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
40.9
39
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
40.9
39
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
413.0
40.4
40
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
413.0
40.4
40
*
N03AX14
ATC
levetiracetam; systemic
13.0
40.2
72
59
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
10.9
38.9
76
75
R51.80
ICD-10 Finland
Headache
3.7
35.2
168
512
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
+∞
33.5
32
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
31.4
230
948
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
25.1
29.4
41
17
AAF00
NOMESCO Finland
Ventriculostomy
58.5
29.3
34
6
G91.0
ICD-10 Finland
Communicating hydrocephalus
28.9
29.1
39
14
B01AA03
ATC
warfarin; systemic
2.3
29.0
356
1936
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.7
28.1
99
226
K91
ICPC
Cerebrovascular disease
23.1
28.0
40
18
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
277.9
26.8
27
*
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
99.4
26.8
29
*
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
26.1
25
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
7.3
25.5
62
89
AAD12
NOMESCO Finland
Drainage of subdural fluid
51.4
25.3
30
6
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.1
25.0
377
2214
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
245.4
23.7
24
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.2
22.7
45
46
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.5
22.7
114
358
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.9
22.4
97
269
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
22.4
221
1057
R42
ICD-10 Finland
Dizziness and giddiness
2.2
21.7
263
1387
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
117.5
21.6
23
*
XA800
NOMESCO Finland
Neuropsychological investigation
7.8
21.6
50
67
T90.5
ICD-10 Finland
Sequelae of intracranial injury
11.5
21.6
40
36
WX002
NOMESCO Finland
Sedation and analgesia
2.3
21.5
243
1240
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.4
21.3
107
336
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
20.9
20
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
9.7
20.7
42
45
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
9.1
20.0
42
48
R53
ICD-10 Finland
Malaise and fatigue
2.2
19.3
238
1255
N02BE01
ATC
paracetamol; systemic, rectal
2.1
19.0
832
6979
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
19.0
658
5072
N03AF02
ATC
oxcarbazepine; oral
6.3
18.7
50
83
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
14.5
18.6
31
22
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.8
18.4
80
223
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
7.8
18.3
42
56
N03AB02
ATC
phenytoin; systemic
10.9
18.0
34
32
R41.0
ICD-10 Finland
Disorientation, unspecified
4.3
17.8
67
164
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
12.7
17.7
31
25
N03AG01
ATC
valproic acid; systemic, rectal
4.3
17.7
67
165
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
29.3
17.5
23
8
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.2
17.4
68
172
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
16.7
16
*
C07AB07
ATC
bisoprolol; oral
1.7
16.3
555
4152
N19
ICPC
Speech disorder
13.8
16.0
27
20
N18
ICPC
Paralysis/weakness
9.7
16.0
32
34
S06.0
ICD-10 Finland
Concussion
2.7
15.8
116
468
S06.3
ICD-10 Finland
Focal brain injury
8.5
15.8
34
41
AA1AA
NOMESCO Finland
Head X-ray examination
10.6
15.8
30
29
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
26.7
15.6
21
8
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.7
15.1
51
112
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
15.1
117
488
N05AH04
ATC
quetiapine; oral
2.3
15.0
146
685
R47.0
ICD-10 Finland
Dysphasia and aphasia
25.4
14.7
20
8
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
14.6
14
*
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
14.6
14
*
PA2AD
NOMESCO Finland
CT angiography of brain
43.1
14.1
17
*
R4120
NOMESCO Finland
Occupational therapy
3.6
14.0
63
182
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
13.9
202
1127
SPAT1216
SPAT
Assessment of functional ability
2.0
13.9
200
1111
N80
ICPC
Head injury other
6.7
13.6
34
52
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
+∞
13.6
13
*
S06.9
ICD-10 Finland
Intracranial injury, unspecified
16.4
13.5
21
13
WX110
NOMESCO Finland
Local anesthesy
1.6
13.3
567
4412
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.1
13.1
74
251
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
19.3
12.9
19
10
P20
ICPC
Memory disturbance
2.0
12.9
176
953
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
12.8
196
1110
H53.4
ICD-10 Finland
Visual field defects
7.3
12.8
30
42
SPAT1234
SPAT
Support of social functional capacity
2.8
12.6
81
300
R4150
NOMESCO Finland
Neuropsychological rehabilitation
70.7
12.6
14
*
SPAT1229
SPAT
Assessment of need for aid
2.4
12.6
110
488
G91.1
ICD-10 Finland
Obstructive hydrocephalus
20.3
12.5
18
9
N06AX11
ATC
mirtazapine; oral
1.7
12.3
279
1807
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.6
12.0
54
156
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
11.9
460
3448
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
47.2
11.9
14
*
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
9.1
11.8
24
27
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
5.3
11.7
35
68
I63.8
ICD-10 Finland
Other cerebral infarction
+∞
11.5
11
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
11.5
11
*
X58
ICD-10 Finland
Exposure to other specified factors
2.2
11.4
122
597
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
35.4
11.3
14
*
L28
ICPC
Limited function/disability (L)
1.9
11.1
191
1126
Y96.9
ICD-10 Finland
Unspecified type of accident
5.8
10.9
30
53
N05AX08
ATC
risperidone; systemic
2.3
10.6
100
461
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
+∞
10.4
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
10.4
99
458
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
10.4
188
1124
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
32.9
10.3
13
*
PA7BD
NOMESCO Finland
CT angiography of neck and brain
7.2
10.3
24
34
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.7
10.2
68
261
N05CF01
ATC
zopiclone; oral
1.6
10.1
339
2423
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
10.1
139
755
AA5PD
NOMESCO Finland
CT examination of brain pefusion
40.5
10.0
12
*
C09AA02
ATC
enalapril; systemic
1.7
9.9
240
1568
G40.10
ICD-10 Finland
Simple partial seizures
11.5
9.6
17
15
SPAT1053
SPAT
Memory test
1.7
9.5
215
1377
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
9.4
276
1900
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
9.4
9
*
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
+∞
9.4
9
*
I62
ICD-10 Finland
Other nontraumatic intracranial haemorrhage
+∞
9.4
9
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
9.4
9
*
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
+∞
9.4
9
*
R11
ICD-10 Finland
Nausea and vomiting
2.4
9.4
79
345
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
21.9
9.4
13
6
WX892
NOMESCO Finland
Monitored bed care
2.3
9.3
84
381
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.8
8.9
56
206
WX882
NOMESCO Finland
High dependency care
3.5
8.9
40
117
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
18.8
8.9
13
7
FFW96
NOMESCO Finland
Other operation on atria
24.2
8.9
12
5
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.2
8.9
45
145
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
8.9
203
1300
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.0
8.7
47
159
N03AF01
ATC
carbamazepine; oral, rectal
2.7
8.6
58
224
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
8.6
309
2229
N05BA04
ATC
oxazepam; oral
1.6
8.5
221
1466
S01.0
ICD-10 Finland
Open wound of scalp
2.2
8.4
86
413
ABB40
NOMESCO Finland
Evacuation of spontaneous haematoma of spinal canal
90.7
8.4
9
*
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
90.7
8.4
9
*
N29
ICPC
Neurological sympt/complt other
4.5
8.4
28
63
F05.9
ICD-10 Finland
Delirium, unspecified
3.7
8.4
35
97
A28
ICPC
Limited function/disability NOS
1.7
8.4
188
1198
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
+∞
8.3
8
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
33.6
8.1
10
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
9.0
8.0
16
18
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.1
8.0
85
414
SPAT1254
SPAT
Administration of medicine
1.7
8.0
163
1007
C10AA01
ATC
simvastatin; oral
1.5
7.9
472
3783
R50.9
ICD-10 Finland
Fever, unspecified
1.8
7.8
137
808
G81.9
ICD-10 Finland
Hemiplegia, unspecified
9.5
7.8
15
16
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.1
7.7
91
463
B01AC07
ATC
dipyridamole; systemic
2.3
7.6
70
320
R55
ICD-10 Finland
Syncope and collapse
1.8
7.6
128
744
S06.4
ICD-10 Finland
Epidural haemorrhage
25.2
7.6
10
*
N99
ICPC
Neurological disease other
6.2
7.6
19
31
G72.8
ICD-10 Finland
Other specified myopathies
4.2
7.5
27
66
J01MA02
ATC
ciprofloxacin; systemic
1.5
7.5
394
3064
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
7.5
236
1640
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.3
7.4
35
108
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
3.3
7.4
35
108
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
80.6
7.4
8
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
7.3
112
629
I60.6
ICD-10 Finland
Subarachnoid haemorrhage from other intracranial arteries
+∞
7.3
7
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
+∞
7.3
7
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
7.3
7
*
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
+∞
7.3
7
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
9.4
7.3
14
15
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.9
7.3
104
570
X57
ICD-10 Finland
Unspecified privation
3.7
7.1
29
80
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.5
7.1
53
219
XX3XW
NOMESCO Finland
NA
12.1
7.1
12
10
A04
ICPC
Weakness/tiredness general
1.8
7.1
124
732
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
10.1
7.0
13
13
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
7.0
7.0
16
23
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
6.4
6.9
17
27
W10
ICD-10 Finland
Fall on and from stairs and steps
2.6
6.9
49
197
N03AX18
ATC
lacosamide; systemic
13.9
6.9
11
8
B01AB05
ATC
enoxaparin; parenteral
1.5
6.9
285
2103
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
6.8
148
931
SPAT1360
SPAT
Extensive global examination
2.0
6.8
81
416
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.8
6.8
27
73
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.4
6.8
19
36
ZXA05
NOMESCO Finland
Left side
1.5
6.8
256
1850
Z43.0
ICD-10 Finland
Attention to tracheostomy
40.3
6.8
8
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
40.3
6.8
8
*
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
5.0
6.7
20
41
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
22.7
6.7
9
*
G30.8
ICD-10 Finland
Other Alzheimer disease
3.0
6.6
36
124
PA6AD
NOMESCO Finland
CT of neck arteries
8.8
6.6
13
15
N28
ICPC
Limited function/disability (N)
4.4
6.6
22
51
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
6.5
146
927
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
6.5
68
333
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
6.4
188
1279
T24.3
ICD-10 Finland
Burn of third degree of hip and lower limb, except ankle and foot
70.2
6.4
7
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
6.3
64
307
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
6.3
48
201
J01DB01
ATC
cefalexin; oral
1.4
6.3
708
6271
N88
ICPC
Epilepsy
18.1
6.3
9
5
F03
ICD-10 Finland
Unspecified dementia
2.1
6.3
70
349
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
6.3
6
*
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
6.3
6
*
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
+∞
6.3
6
*
C03AA03
ATC
hydrochlorothiazide; oral
1.8
6.2
108
635
K78
ICPC
Atrial fibrillation/flutter
1.8
6.2
106
619
N05CD07
ATC
temazepam; oral
1.6
6.2
146
942
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
5.8
6.2
16
28
C03CA01
ATC
furosemide; systemic
1.4
6.1
381
3035
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.6
6.1
43
172
G40.89
ICD-10 Finland
Other epilepsy
12.6
6.1
10
8
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
12.6
6.1
10
8
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
12.6
6.1
10
8
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
6.1
65
321
SPAT1252
SPAT
Overall medication plan or its review
1.9
6.0
83
450
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
4.2
6.0
21
51
R1250
NOMESCO Finland
Evaluation of functional capability
3.6
6.0
25
71
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.7
6.0
126
785
N05AA02
ATC
levomepromazine; systemic
2.7
6.0
39
149
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
323
1254
3.21
62.61
2.3
1.9
30.4
30.2
s
0.17
314
1211
477
2473
2.61
52.05
2.9
2.0
281.7
289.1
u/l
0.04
461
2286
52
65
8.34
39.08
2.1
1.3
—
—
—
0
0
744
5220
2.26
35.70
7.6
4.8
6.9
6.9
mmol/l
0.09
719
4919
69
142
5.11
31.99
2.2
1.3
47.9
66.9
e6/l
0.14
55
113
69
142
5.11
31.99
2.3
1.4
31173.3
1071.7
e6/l
0.51
59
117
592
3906
2.09
31.79
5.0
4.3
—
—
—
0
0
35
37
9.73
29.85
1.8
2.6
—
—
—
0
0
281
1420
2.31
29.53
3.2
3.1
0.8
0.8
mmol/l
0.10
271
1312
361
2088
2.07
26.56
3.2
2.5
—
—
—
0
0
27
28
9.86
23.29
2.0
1.3
—
—
—
0
0
535
3678
1.87
22.82
5.2
4.1
37.2
60.2
ng/l
1.32
455
2835
225
1156
2.18
22.07
8.5
6.8
1.2
1.3
mmol/l
0.09
174
877
221
1152
2.14
20.79
8.6
6.9
4.9
5.1
kpa
1.70
210
1093
220
1151
2.13
20.48
8.6
6.9
13.4
11.6
kpa
4.00
209
1092
618
4586
1.77
19.25
9.1
7.0
1.2
1.2
mmol/l
1.58
531
3856
250
1416
1.98
18.58
37.6
30.6
1.7
1.5
inr
0.91
44
196
220
1226
1.99
16.99
8.6
6.7
105.4
104.3
mmol/l
2.63
212
1198
173
885
2.13
16.85
6.1
6.6
10.2
11.6
mmol/l
1.64
167
841
220
1230
1.98
16.82
5.4
5.5
1.0
1.0
mmol/l
0.81
209
1135
179
942
2.07
16.15
9.4
7.6
116.7
120.3
g/l
1.51
174
904
57
173
3.42
15.77
2.5
2.5
28.7
32.9
umol/l
0.91
51
139
552
4160
1.64
14.67
8.7
6.1
1.2
1.2
mmol/l
3.06
498
3722
60
202
3.08
14.04
3.3
2.2
3.8
3.6
g/l
0.23
55
192
590
4572
1.61
13.62
7.6
6.2
12.7
12.7
umol/l
0.01
549
4326
126
618
2.17
13.57
9.6
8.7
1.4
1.3
%
0.34
126
613
129
658
2.09
12.54
9.9
6.0
24.8
24.4
mmol/l
0.63
123
614
698
5714
1.58
12.14
6.1
4.8
1714.2
2179.8
e6/l
0.15
18
108
77
321
2.50
12.05
5.8
3.5
3.9
4.0
mmol/l
1.65
70
298
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
81
350
2.42
11.74
3.3
2.5
0.3
0.3
u/ml
0.10
42
190
24
51
4.79
10.74
1.7
1.3
1.2
1.0
promille
0.14
19
35
299
2066
1.61
10.51
2.0
1.8
1178.5
1188.0
nmol/l
0.06
231
1524
143
807
1.88
10.37
5.1
3.1
4.8
4.4
kpa
0.80
138
782
256
1711
1.64
10.26
1.9
1.9
—
—
—
0
0
267
1805
1.63
10.22
4.7
4.1
134.7
323.4
ng/l
2.67
227
1557
123
669
1.94
9.96
4.4
4.4
5.2
5.2
kpa
0.12
111
612
163
973
1.79
9.85
5.7
3.6
1.3
2.1
mmol/l
1.45
131
764
162
979
1.77
9.37
5.8
3.6
5.7
5.8
kpa
0.96
156
946
499
3948
1.47
9.09
5.6
4.7
33.5
34.6
g/l
4.15
465
3635
98
510
2.01
9.00
9.6
9.6
24.0
24.5
mmol/l
1.06
92
466
438
3392
1.48
8.82
3.8
3.4
—
—
—
0
0
113
627
1.89
8.61
4.4
4.4
1.4
2.1
mmol/l
0.82
80
473
144
863
1.77
8.55
9.2
7.1
1.3
1.4
mmol/l
0.35
136
825
120
682
1.85
8.49
1.7
1.6
—
—
—
0
0
88
459
2.00
8.04
2.1
1.8
3.4
2.4
ug/l
0.25
69
407
16
31
5.22
7.94
1.0
1.1
—
—
—
0
0
106
592
1.87
7.92
1.6
1.5
—
—
—
0
0
112
643
1.82
7.67
5.3
3.4
126.3
126.6
g/l
0.03
107
629
58
263
2.27
7.60
4.1
4.1
7.8
7.8
kpa
0.00
50
240
355
2730
1.44
7.06
3.1
2.5
60.5
57.3
u/l
0.51
329
2503
560
4685
1.39
6.78
10.8
8.6
4.4
4.3
e9/l
0.25
490
4046
323
2468
1.43
6.58
3.5
3.0
32.5
35.1
u/l
0.64
304
2341
58
281
2.12
6.50
3.3
3.1
24.8
25.1
mmol/l
0.15
46
234
744
6563
1.40
6.33
9.6
7.5
84.7
81.2
u/l
0.92
697
6109
328
2528
1.42
6.33
2.2
2.2
3.5
3.1
mg/l
1.52
274
2128
174
1182
1.56
6.31
1.7
1.8
—
—
—
0
0
880
8009
1.45
6.17
26.7
17.0
26.9
28.2
mg/l
0.57
790
6497
231
1675
1.48
6.15
2.2
1.6
2.0
1.5
mg/l
0.81
187
1326
379
3043
1.37
5.61
3.3
3.4
2.3
2.3
mmol/l
0.10
326
2586
72
399
1.86
5.56
2.1
1.7
—
—
—
0
0
171
1189
1.52
5.55
4.4
4.0
243.0
244.6
u/l
0.06
160
1108
181
1275
1.50
5.53
3.0
2.5
1.8
1.8
%
0.05
159
1118
169
1180
1.51
5.38
1.8
1.8
—
—
—
0
0
83
487
1.76
5.33
5.4
2.8
0.7
0.6
%
0.88
83
470
278
2137
1.40
5.32
1.7
1.8
418.6
6775183.9
pmol/l
0.80
224
1727
412
3374
1.35
5.31
3.0
2.8
186.6
159.9
ug/l
0.93
368
3034
395
3231
1.34
5.08
3.8
3.2
1841.1
1859.4
ng/l
0.04
354
2811
53
275
1.97
5.00
2.9
3.1
0.9
0.8
nmol/l
0.52
36
209
75
437
1.77
4.94
2.3
1.9
—
—
—
0
0
538
4626
1.31
4.80
4.2
3.1
73.7
56.7
u/l
1.45
491
4181
134
913
1.53
4.78
2.8
2.6
3.8
6.0
ug/l
3.18
117
789
263
2044
1.37
4.65
3.2
2.6
3.7
4.2
e6/l
0.39
235
1798
192
1422
1.42
4.49
2.8
2.6
2.2
2.2
g/l
0.39
172
1309
235
1815
1.37
4.29
5.7
4.2
1.0
1.0
kg/l
1.17
42
281
299
2406
1.33
4.16
1.8
1.6
19.6
19.8
nmol/l
0.05
257
2014
88
565
1.60
4.08
3.5
2.7
0.6
0.4
e6/l
0.46
88
554
67
404
1.70
3.96
5.6
5.2
24.3
25.0
mmol/l
1.20
62
377
55
314
1.79
3.93
1.4
1.2
—
—
—
0
0
69
421
1.68
3.91
7.4
4.3
1.5
1.6
%
0.26
64
394
8
11
7.32
3.86
1.0
1.1
—
—
—
0
0
9
15
6.04
3.82
1.1
1.1
—
—
—
0
0
6
5
12.05
3.76
1.0
1.4
—
—
—
0
0
38
196
1.97
3.71
1.3
1.6
—
—
—
0
0
9
16
5.66
3.66
1.0
1.1
—
—
—
0
0
9
16
5.66
3.66
1.0
1.1
—
—
—
0
0
9
16
5.66
3.66
1.1
1.2
—
—
—
0
0
9
16
5.66
3.66
1.1
1.3
—
—
—
0
0
902
8467
1.33
3.55
31.3
20.5
139.5
139.6
mmol/l
0.89
884
8210
201
1560
1.35
3.53
2.8
2.6
12.3
12.0
umol/l
0.22
182
1430
178
1357
1.37
3.50
2.9
2.6
22.1
21.9
%
0.03
152
1148
6
6
10.04
3.50
1.2
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
36
3.36
3.48
1.0
1.2
—
—
—
0
0
97
663
1.51
3.45
2.0
2.2
353.3
369.2
nmol/l
0.41
87
596
278
2267
1.30
3.45
5.2
4.2
0.0
0.0
estimate
0.50
76
733
902
8479
1.32
3.43
31.2
20.6
4.0
4.0
mmol/l
0.32
883
8217
452
3919
1.26
3.40
2.4
2.1
88.9
92.1
pmol/l
0.81
276
2098
32
163
1.99
3.26
10.3
2.3
64.2
62.0
%
0.19
32
163
6
7
8.61
3.26
1.2
1.4
—
—
—
0
0
464
4050
1.25
3.26
5.0
3.9
0.0
0.0
estimate
0.00
79
777
130
952
1.41
3.25
3.6
2.6
8.1
10.1
umol/l
1.09
117
844
16
60
2.69
3.23
1.8
1.3
—
—
—
0
0
152
1147
1.38
3.18
10.3
8.7
—
—
—
0
0
16
61
2.65
3.14
1.8
1.3
—
—
—
0
0
17
68
2.52
3.05
1.8
1.1
8.2
2.9
u/ml
0.56
11
27
100
707
1.45
3.03
3.5
3.9
109.4
99.8
ng/l
0.46
83
610
24
113
2.15
3.02
1.1
1.2
—
—
—
0
0
465
4085
1.24
3.01
5.1
3.9
0.0
0.0
estimate
0.50
78
756
366
3132
1.25
3.01
5.5
4.2
—
—
—
0
0
382
3286
1.25
3.00
2.4
2.2
75.7
78.7
nmol/l
1.19
336
2825
46
273
1.71
2.95
1.8
1.8
—
—
—
0
0
309
2600
1.26
2.94
3.8
3.4
0.6
0.5
e6/l
0.36
257
2035
458
4026
1.23
2.93
6.8
5.3
0.0
0.0
estimate
0.00
83
773
77
529
1.49
2.72
1.8
1.9
1.5
1.5
g/l
0.18
63
462
93
664
1.44
2.70
1.9
1.7
—
—
—
0
0
8
19
4.23
2.68
12.4
15.7
1112.6
1443.7
nmol/l
—
8
19
8
19
4.23
2.68
8.4
12.6
624.8
833.6
nmol/l
—
8
19
36
208
1.75
2.56
1.4
1.8
—
—
—
0
0
88
629
1.43
2.55
2.1
1.7
1.8
1.6
%
1.24
77
522
5
7
7.17
2.55
1.2
1.4
—
—
—
0
0
15
62
2.44
2.54
1.1
1.1
—
—
—
0
0
6
11
5.48
2.54
1.7
1.0
—
—
—
0
0
6
11
5.48
2.54
1.7
1.0
—
—
—
0
0
21
101
2.10
2.54
3.3
2.8
—
—
—
0
0
13
50
2.62
2.53
2.3
2.4
—
—
—
0
0
13
50
2.62
2.53
1.8
2.2
—
—
—
0
0
10
33
3.05
2.53
1.3
2.7
—
—
—
0
0
10
33
3.05
2.53
1.3
2.7
—
—
—
0
0
7
16
4.40
2.47
1.0
1.3
—
—
—
0
0
9
27
3.35
2.39
1.0
1.2
—
—
—
0
0
38
228
1.69
2.39
1.8
2.3
129.4
127.7
g/l
0.16
32
169
116
881
1.35
2.37
3.0
2.7
65.7
65.9
g/l
0.11
105
789
12
46
2.63
2.36
1.9
1.3
—
—
—
0
0
12
46
2.63
2.36
1.9
1.3
—
—
—
0
0
655
6052
1.20
2.31
4.6
4.1
16.5
14.5
mm/h
1.78
602
5466
130
1011
1.32
2.27
3.8
3.8
—
—
—
0
0
21
106
2.00
2.26
1.0
1.2
246.0
294.2
u/ml
0.40
13
59
185
1509
1.27
2.26
3.4
3.2
2.0
1.9
e6/l
0.06
116
897
46
295
1.58
2.25
1.5
1.6
—
—
—
0
0
93
689
1.38
2.23
3.5
3.1
55.5
58.0
ml/min/173m2
0.22
38
297
10
37
2.72
2.10
2.2
1.4
65.4
62.5
umol/l
—
5
24
19
98
1.95
1.96
1.9
1.6
—
—
—
0
0
28
165
1.71
1.92
1.7
1.7
—
—
—
0
0
35
221
1.60
1.87
2.3
2.6
16.3
15.6
%
0.69
22
116
6
17
3.54
1.84
1.5
2.0
—
—
—
0
0
37
238
1.57
1.83
1.7
1.4
269.4
262.8
ug/g
0.07
20
143
30
186
1.63
1.73
3.4
3.9
1.7
1.6
%
0.07
15
142
188
1586
1.22
1.72
3.2
3.0
1.0
1.1
e6/l
0.20
118
968
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
25
148
1.70
1.71
1.4
1.2
—
—
—
0
0
48
333
1.46
1.70
2.3
2.5
0.6
1.5
g/l
1.78
39
278
877
8417
1.19
1.65
13.9
10.9
25.1
24.7
u/l
0.26
838
8004
13
63
2.08
1.60
1.1
1.0
177.8
312.0
ng/l
—
5
38
13
63
2.08
1.60
1.1
1.0
411.8
634.6
ng/l
—
5
37
13
63
2.08
1.60
1.1
1.0
26.8
44.4
ng/l
—
5
36
905
8718
1.20
1.60
37.6
25.1
129.4
133.0
g/l
8.93
889
8509
7
26
2.70
1.58
1.3
1.1
—
—
—
0
0
7
27
2.60
1.51
1.1
1.1
—
—
—
0
0
11
51
2.17
1.51
1.4
1.2
—
—
—
0
0
41
284
1.46
1.49
1.9
2.2
0.0
0.0
g/l
1.35
35
258
5
17
2.95
1.36
1.4
1.0
1646.4
1307.2
miu/ml
—
5
17
205
1786
1.18
1.34
3.1
3.1
2.5
2.5
mmol/l
0.27
183
1548
48
353
1.38
1.29
4.3
3.5
48.2
74.2
mg/l
0.77
40
289
47
345
1.38
1.28
4.2
3.5
2.5
2.1
ratio
—
5
32
49
364
1.36
1.25
1.8
2.4
3.3
3.2
g/l
0.26
34
282
265
2372
1.15
1.23
3.8
2.9
374.5
7820.4
umol/l
9.52
219
1999
11
56
1.97
1.22
2.8
3.3
44.6
39.5
u/ml
0.08
11
56
15
86
1.75
1.19
1.3
1.3
—
—
—
0
0
12
65
1.86
1.13
1.2
1.1
114.6
108.4
%
0.22
12
56
52
397
1.32
1.13
1.7
2.3
4.1
3.8
g/l
0.51
34
275
748
7175
1.13
1.12
4.8
4.4
2.1
2.1
mu/l
0.10
667
6333
52
398
1.32
1.11
1.7
2.3
—
—
—
0
0
10
51
1.97
1.11
1.1
1.1
—
—
—
0
0
7
31
2.27
1.10
3.0
3.0
—
—
—
0
0
52
399
1.32
1.10
1.7
2.3
7.4
7.5
g/l
0.06
35
286
41
304
1.36
1.08
1.9
2.1
37.6
37.1
g/l
0.21
31
254
7
32
2.19
1.08
1.0
1.0
—
—
—
0
0
50
388
1.30
0.99
3.2
2.9
—
—
—
0
0
35
258
1.37
0.98
1.9
2.4
129.9
95.1
ug/min
0.24
22
152
46
354
1.31
0.97
4.4
3.6
34.1
78.2
mg/l
0.71
39
294
36
269
1.35
0.93
1.0
1.0
—
—
—
0
0
8
42
1.91
0.88
1.1
1.3
—
—
—
0
0
8
42
1.91
0.88
5.8
6.6
64.3
74.6
%
—
8
33
101
863
1.19
0.87
2.9
2.1
0.2
0.2
g/l
0.16
94
800
6
31
1.94
0.84
1.2
1.0
—
—
—
0
0
6
31
1.94
0.84
4.2
1.7
800.5
1733.5
u/ml
—
6
31
403
3782
1.10
0.84
2.6
2.4
—
—
—
0
0
775
7505
1.11
0.83
6.8
6.5
41.7
41.0
mmol/mol
1.10
704
6775
15
97
1.55
0.81
1.3
1.9
—
—
—
0
0
6
33
1.82
0.79
1.3
1.6
—
—
—
0
0
25
337
0.74
0.77
1.6
1.8
—
—
—
0
0
22
157
1.41
0.77
1.5
1.3
14248.4
111415.8
e6/l
1.46
15
95
9
53
1.70
0.75
1.7
1.4
—
—
—
0
0
9
53
1.70
0.75
1.7
1.4
—
—
—
0
0
11
67
1.65
0.75
1.3
1.1
—
—
—
0
0
5
24
2.09
0.74
1.2
1.0
194.6
163.4
iu/ml
—
5
24
767
7443
1.10
0.74
23.9
16.3
70.4
72.1
ml/min/173m2
1.27
665
6164
67
794
0.83
0.73
1.3
1.3
—
—
—
0
0
5
25
2.00
0.72
2.0
1.1
—
—
—
0
0
7
39
1.80
0.72
1.1
1.3
0.2
0.2
nmol/l
—
7
26
14
92
1.53
0.72
1.4
1.9
—
—
—
0
0
17
117
1.46
0.72
1.6
1.4
—
—
—
0
0
46
374
1.24
0.69
1.8
2.3
11.0
10.4
g/l
0.35
35
313
320
2998
1.09
0.68
4.1
4.0
13.6
8.8
mg/mmol
0.95
230
1952
39
311
1.26
0.68
1.8
2.0
37.3
37.9
u/l
0.07
32
265
89
772
1.17
0.68
4.4
3.8
1.2
1.2
mmol/l
0.67
78
664
18
127
1.42
0.68
2.9
3.5
—
2769.4
—
0
16
17
119
1.44
0.67
1.6
1.4
—
—
—
0
0
17
119
1.44
0.67
1.6
1.4
—
—
—
0
0
17
119
1.44
0.67
1.1
1.1
—
—
—
0
0
17
119
1.44
0.67
1.6
1.4
—
—
—
0
0
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
11
70
1.58
0.65
1.1
1.2
—
—
—
0
0
17
120
1.42
0.64
1.6
1.4
—
—
—
0
0
17
120
1.42
0.64
1.6
1.4
—
—
—
0
0
23
172
1.34
0.64
1.1
1.4
—
—
—
0
0
27
208
1.31
0.62
1.4
1.4
—
—
—
0
0
96
1085
0.87
0.61
1.2
1.2
15.0
13.8
u/ml
0.06
30
377
8
51
1.57
0.60
1.3
1.1
—
11.0
—
0
15
8
51
1.57
0.60
1.0
1.0
—
—
—
0
0
23
174
1.33
0.60
1.6
1.4
743.2
1731.3
e6/l
2.50
18
127
747
7274
1.08
0.59
4.1
4.1
1.3
1.3
mmol/l
0.52
669
6397
19
140
1.36
0.58
1.1
1.5
—
—
—
0
0
44
364
1.22
0.58
2.8
3.1
4.3
4.4
pmol/l
0.16
38
312
10
148
0.67
0.55
1.0
1.1
—
—
—
0
0
8
122
0.65
0.55
1.6
1.9
223.5
229.3
pmol/l
—
8
113
23
178
1.30
0.53
1.4
1.7
—
—
—
0
0
6
40
1.50
0.51
1.0
1.3
—
—
—
0
0
6
40
1.50
0.51
1.0
1.3
—
—
—
0
0
19
247
0.77
0.50
1.7
1.7
—
—
—
0
0
107
966
1.12
0.50
3.4
3.1
336.7
249.0
ng/l
0.58
101
888
596
5782
1.07
0.49
4.0
3.6
15.1
15.1
pmol/l
0.02
535
5093
7
45
1.56
0.49
1.4
1.1
—
—
—
0
0
23
181
1.28
0.48
1.5
1.2
3.3
7.4
u/ml
—
5
22
7
47
1.49
0.47
1.0
1.3
213.4
480.9
u/l
—
7
42
192
2055
0.92
0.47
1.7
1.6
1.4
1.3
mmol/l
0.47
155
1672
13
94
1.39
0.46
1.5
1.2
0.7
0.6
nmol/l
0.20
13
87
5
83
0.60
0.45
1.2
1.1
—
—
—
0
0
12
86
1.40
0.44
1.3
1.3
—
—
—
0
0
13
95
1.37
0.44
1.2
1.4
16.6
14.3
u/l
0.46
13
87
301
2871
1.07
0.41
3.4
3.2
7.2
7.4
mmol/l
0.29
250
2355
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
11
149
0.74
0.40
3.6
3.1
4.4
4.5
e9/l
0.05
11
149
22
270
0.81
0.39
1.7
1.8
—
—
—
0
0
22
178
1.24
0.39
1.4
1.6
—
—
—
0
0
5
36
1.39
0.38
1.0
1.3
—
—
—
0
0
25
206
1.22
0.38
1.3
1.2
—
—
—
0
0
12
89
1.35
0.38
1.5
1.9
—
—
—
0
0
450
4357
1.05
0.37
5.5
5.7
8.5
4.5
ug/l
0.39
400
3824
106
1149
0.91
0.36
1.2
1.3
66.3
39.6
iu/ml
0.56
34
349
42
366
1.15
0.36
4.3
3.2
337.3
4548.5
u/ml
0.86
36
308
25
210
1.19
0.33
1.6
1.3
—
—
—
0
0
25
210
1.19
0.33
1.6
1.3
—
—
—
0
0
6
47
1.28
0.32
2.3
3.7
105.7
115.3
nmol/l
—
6
47
19
156
1.22
0.31
1.1
1.4
—
—
—
0
0
7
53
1.32
0.31
3.3
3.8
—
—
—
0
0
52
577
0.90
0.30
1.4
1.4
—
—
—
0
0
12
152
0.79
0.29
3.7
3.5
60.0
59.2
%
0.11
12
152
7
57
1.23
0.29
2.4
3.8
—
—
—
0
0
27
233
1.16
0.27
1.4
1.7
—
—
—
0
0
21
177
1.19
0.27
1.0
1.1
—
6.9
—
0
14
8
65
1.23
0.27
1.4
1.2
—
—
—
0
0
21
246
0.85
0.26
1.2
1.3
—
—
—
0
0
17
141
1.21
0.26
1.4
1.5
2.6
6.4
iu/l
—
7
41
361
3508
1.04
0.26
4.8
4.9
23.3
22.0
%
0.93
196
1897
37
330
1.13
0.25
1.1
1.2
93.4
147.2
iu/ml
0.65
15
114
5
38
1.32
0.23
1.2
1.4
1.0
1.0
g/l
—
5
38
5
41
1.22
0.22
1.8
1.8
—
—
—
0
0
5
41
1.22
0.22
1.8
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
0.8
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
787
7783
1.04
0.21
5.1
5.1
6.2
6.1
mmol/l
0.67
694
6871
5
43
1.16
0.21
1.8
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
9
111
0.81
0.20
2.8
3.3
—
—
—
0
0
6
53
1.13
0.18
1.2
1.6
—
—
—
0
0
14
164
0.85
0.18
1.1
1.5
1.6
0.8
nmol/l
—
8
136
12
100
1.20
0.18
1.1
1.0
—
—
—
0
0
24
214
1.12
0.17
1.3
1.6
21310.0
19266.6
e6/l
0.09
14
151
25
225
1.11
0.16
1.5
1.5
0.2
24.2
iu/ml
—
8
50
8
71
1.13
0.16
1.1
1.5
—
—
—
0
0
8
72
1.11
0.16
1.3
2.0
—
—
—
0
0
6
77
0.78
0.15
1.0
1.0
—
1.4
—
0
27
24
265
0.90
0.15
1.3
1.2
—
—
—
0
0
643
6361
1.03
0.15
30.4
20.5
14.2
13.9
%
3.96
635
6202
696
6900
1.02
0.12
27.9
18.2
38.1
38.7
%
0.67
393
4158
16
143
1.12
0.11
1.2
1.4
—
—
—
0
0
768
7629
1.02
0.11
4.6
4.6
4.2
4.4
mmol/l
8.61
695
6834
15
166
0.90
0.09
1.7
1.7
45.6
42.2
nmol/l
0.34
15
156
73
756
0.96
0.09
3.6
2.6
30.2
32.5
u/l
0.41
66
634
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
789
7852
1.02
0.08
5.1
5.2
2.4
2.6
mmol/l
8.07
706
6991
22
206
1.07
0.07
1.3
1.1
—
—
—
0
0
9
86
1.05
0.07
1.3
1.4
—
—
—
0
0
9
87
1.03
0.07
1.2
1.6
—
—
—
0
0
12
132
0.91
0.06
1.4
1.4
7.1
6.3
mmol/l
0.47
12
124
16
148
1.08
0.06
1.1
1.1
—
—
—
0
0
108
1058
1.02
0.06
4.2
4.0
54.5
33.1
ug/l
0.25
95
896
22
207
1.06
0.06
1.3
1.1
—
—
—
0
0
11
100
1.10
0.05
2.0
2.0
—
—
—
0
0
23
218
1.06
0.05
3.1
3.5
28.2
30.5
mg/l
0.10
17
140
23
242
0.95
0.05
1.3
1.5
—
—
—
0
0
139
1408
0.99
0.04
1.2
1.2
0.8
1.2
u/ml
0.85
33
338
13
121
1.08
0.03
1.9
1.3
—
—
—
0
0
109
1099
0.99
0.01
5.0
4.7
33.4
32.6
%
0.25
68
692
66
668
0.99
0.01
2.2
2.2
12.6
12.0
nmol/l
0.17
58
571
25
244
1.03
0.00
1.3
1.6
—
—
—
0
0
10
96
1.04
0.00
1.4
1.4
84.6
68.5
%
—
5
70
11
114
0.96
0.00
1.3
1.3
—
—
—
0
0
19
188
1.01
0.00
1.4
1.6
3.0
3.2
mg/l
0.04
12
147
14
141
0.99
0.00
1.3
1.6
—
—
—
0
0
247
2471
1.00
0.00
3.4
3.4
1.2
0.8
ug/l
1.24
171
1775
12
117
1.03
0.00
3.1
2.3
3.2
381.5
u/ml
0.56
12
112
14
143
0.98
0.00
1.4
1.3
—
—
—
0
0
10
95
1.05
0.00
1.5
1.6
—
—
—
0
0
12
115
1.04
0.00
1.3
1.6
—
—
—
0
0
10
95
1.05
0.00
1.5
1.6
—
—
—
0
0
10
95
1.05
0.00
1.5
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
0.00
1.2
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
7
77
0.91
0.00
1.1
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
1.8
1.7
—
—
—
0
0
5
56
0.89
0.00
1.8
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
753
7530
1.00
0.00
4.6
4.6
1.3
1.4
mmol/l
6.36
672
6681
5
56
0.89
0.00
1.2
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
23.4
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
1.8
1.7
—
—
—
0
0
6
67
0.89
0.00
1.2
1.3
—
60.0
—
0
6
0
7
0.00
0.00
0.0
1.1
—
78.0
—
0
7
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
5
56
0.89
0.00
1.8
1.7
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_OTHINTRACRA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_OTHINTRACRA | 2.148 [1.85, 2.49] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.346 |
During the follow-up period (1.1.1998 — 31.12.2019), 1445 out of 2816 females with I9_OTHINTRACRA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_OTHINTRACRA | 2.024 [1.74, 2.35] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 2569 out of 4843 males with I9_OTHINTRACRA died.
Mortality risk
Mortality risk for people of age
years, who have I9_OTHINTRACRA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.205% | 0.342% |
| 5 | 1.286% | 2.021% |
| 10 | 3.13% | 5.194% |
| 15 | 6.112% | 10.143% |
| 20 | 10.484% | 17.079% |
Relationships between endpoints
↥Index endpoint: I9_OTHINTRACRA – Other intracranial haemorrhages
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data